Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is O  [Clear All Filters]
Journal Article
Park, H.-W., Oh, S., Lee, K.Hee, Lee, B.Hwan, and Chang, M.-S. (2018). Olig2-expressing Mesenchymal Stem Cells Enhance Functional Recovery after Contusive Spinal Cord Injury.Int J Stem Cells.
Sylla, B., Legentil, L., Saraswat-Ohri, S., Vashishta, A., Daniellou, R., Wang, H.-W., Vetvicka, V., and Ferrieres, V. (2014). Oligo-beta-(1→3)-glucans: Impact of thio-bridges on immunostimulating activities and the development of cancer stem cells.J Med Chem.
Nobuta, H., Yang, N., Ng, Y.Han, Marro, S.G., Sabeur, K., Chavali, M., Stockley, J.H., Killilea, D.W., Walter, P.B., Zhao, C., et al. (2019). Oligodendrocyte Death in Pelizaeus-Merzbacher Disease Is Rescued by Iron Chelation.Cell Stem Cell25, 531-541.e6.
Wang, L., Schlagal, C.R., Gao, J., Hao, Y., Dunn, T.J., McGrath, E.L., Labastida, J.Allende, Yu, Y., Feng, S.-Q., Liu, S.-Y., et al. (2018). Oligodendrocyte differentiation from human neural stem cells: A novel role for c-Src.Neurochem Int.
Mi, R., Tammia, M., Shinn, D., Li, Y., Martin, R., Mao, H.-Q., and Höke, A. (2019). Oligodendrocyte Precursors Gain Schwann Cell-Like Phenotype and Remyelinate Axons Upon Engraftment into Peripheral Nerves.J Tissue Eng Regen Med.
Neumann, B., and Kazanis, I. (2016). Oligodendrocyte progenitor cells: the ever mitotic cells of the CNS.Front Biosci (Schol Ed)8, 29-43.
Amaral, A.I., Hadera, M.Ghezu, Kotter, M., and Sonnewald, U. (2016). Oligodendrocytes Do Not Export NAA-Derived Aspartate In Vitro.Neurochem Res.
Wang, J., Bushman, J., Wang, X., Mayer-Proschel, M., Johnson, M., and Noble, M. (2013). Oligodendrocyte/Type-2 astrocyte progenitor cells and glial-restricted precursor cells generate different tumor phenotypes in response to the identical oncogenes.J Neurosci33, 16805-17.
Zhang, R., Chopp, M., and Zhang, Z.Gang (2013). Oligodendrogenesis after cerebral ischemia.Front Cell Neurosci7, 201.
Verdura, S., Cuyàs, E., Lozano-Sánchez, J., Bastidas-Velez, C., Llorach-Parés, L., Fernández-Arroyo, S., Hernández-Aguilera, A., Joven, J., Nonell-Canals, A., Bosch-Barrera, J., et al. (2018). An olive oil phenolic is a new chemotype of mutant isocitrate dehydrogenase 1 (IDH1) inhibitors.Carcinogenesis.
Chen, Y., and Li, S. (2014). Omacetaxine mepesuccinate in the treatment of intractable chronic myeloid leukemia.Onco Targets Ther7, 177-186.
De Carlo, F., Witte, T.R., W Hardman, E., and Claudio, P.Paolo (2013). Omega-3 Eicosapentaenoic Acid Decreases CD133 Colon Cancer Stem-Like Cell Marker Expression While Increasing Sensitivity to Chemotherapy.Plos One8, e69760.
D'Eliseo, D., and Velotti, F. (2016). Omega-3 Fatty Acids and Cancer Cell Cytotoxicity: Implications for Multi-Targeted Cancer Therapy.J Clin Med5.
Shadmani, A., Kazemi, K., Khalili, M.Reza, and Eghtedari, M. (2014). Omental transposition in treatment of severe ocular surface alkaline burn: an experimental study.Med Hypothesis Discov Innov Ophthalmol3, 57-61.
Talekar, M.K., Allen, J.E., Dicker, D.T., and El-Deiry, W.S. (2015). ONC201 Induces Cell Death in Pediatric non-Hodgkin's Lymphoma Cells.Cell Cycle.
Dhiman, N., Kingshott, P., Sumer, H., Sharma, C.S., and Rath, S.Narayan (2019). On-chip anticancer drug screening - Recent progress in microfluidic platforms to address challenges in chemotherapy.Biosens Bioelectron137, 236-254.
Gallego-Perez, D., Chang, L., Shi, J., Ma, J., Kim, S.-H., Zhao, X., Malkoc, V., Wang, X., Minata, M., Kwak, K.Joo, et al. (2016). On-chip clonal analysis of glioma stem cell motility and therapy resistance.Nano Lett.
Akagi, T., Kato, K., Kobayashi, M., Kosaka, N., Ochiya, T., and Ichiki, T. (2015). On-Chip Immunoelectrophoresis of Extracellular Vesicles Released from Human Breast Cancer Cells.Plos One10, e0123603.
Del Gobbo, A., Vaira, V., Rocco, E.Guerini, Palleschi, A., Bulfamante, G., Ricca, D., Fiori, S., Bosari, S., and Ferrero, S. (2014). The Oncofetal Protein IMP3: A Useful Marker to Predict Poor Clinical Outcome in Neuroendocrine Tumors of the Lung.J Thorac Oncol.
Liu, T., and Shyh-Chang, N. (2019). Oncofetal SALL4 driven tumorigenesis is highly dependent on oxidative phosphorylation, revealing therapeutic opportunities.Gastroenterology.
Sotoca, A.M., Prange, K.H.M., Reijnders, B., Mandoli, A., Nguyen, L.N., Stunnenberg, H.G., and Martens, J.H.A. (2015). The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia.Oncogene.
Liu, J., Han, Q., Peng, T., Peng, M., Wei, B., Li, D., Wang, X., Yu, S., Yang, J., Cao, S., et al. (2015). The oncogene c-Jun impedes somatic cell reprogramming.Nat Cell Biol.
Rapin, N., and Porse, B.T. (2014). Oncogenic fusion proteins expressed in immature hematopoietic cells fail to recapitulate the transcriptional changes observed in human AML.Oncogenesis3, e106.
He, F., Melamed, J., Tang, M.-S., Huang, C., and Wu, X.-R. (2015). Oncogenic HRAS activates epithelial-mesenchyme transition and confers stemness to p53-deficient urothelial cells to drive muscle invasion of basal subtype carcinomas.Cancer Res.
Shetzer, Y., Molchadsky, A., and Rotter, V. (2016). Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.Cold Spring Harb Perspect Med.